Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
World J Gastroenterol. 2020 Mar 28;26(12):1298-1316. doi: 10.3748/wjg.v26.i12.1298.
Colorectal cancer (CRC) is one of the most prevalent tumors worldwide. Recently, long noncoding RNAs (lncRNAs) have been shown to influence tumorigenesis and tumor progression by acting as competing endogenous RNAs (ceRNAs). It is difficult to extract prognostic lncRNAs and useful bioinformation from most ceRNA networks constructed previously.
To construct a prognostic related ceRNA regulatory network and lncRNA related signature based on risk score in CRC.
RNA transcriptome profile and clinical information of 506 CRC patients were downloaded from the Cancer Genome Atlas database. R packages and Perl program were used for data processing. Cox regression analysis was used for prognostic model construction. Quantitative real-time polymerase chain reaction was used to detect the expression of lncRNAs.
A prognostic-related ceRNA network was constructed, including 9 lncRNAs, 44 mRNAs, and 30 miRNAs. In addition, a four-lncRNA model was constructed using multivariate Cox regression analysis, which could be an independent prognostic model in CRC. The risk score for each patient was calculated, and the 506 patients were divided into high and low-risk groups (253 for each group) based on the median risk score. The results of the survival analysis showed that patients with a high-risk score had a poor survival rate. Furthermore, the predictive value of the four-lncRNA model was evaluated in GSE38832. Patient survival probabilities could be better predicted when combing the risk score and clinical features. Gene Set Enrichment Analysis results verified that a number of cancer-related signaling pathways were enriched with a high-risk score in CRC. Finally, we validated a novel lncRNA () using quantitative real-time polymerase chain reaction in 22 paired CRC patient tumor tissues compared to adjacent non-tumor tissues.
The four-lncRNA model could give better predictive value for CRC patients. Our understanding of the lncRNA-related ceRNA regulatory mechanism could provide a potential diagnostic indicator for CRC patients.
结直肠癌(CRC)是全球最常见的肿瘤之一。最近,长链非编码 RNA(lncRNA)已被证明可通过充当竞争性内源 RNA(ceRNA)来影响肿瘤发生和肿瘤进展。从以前构建的大多数 ceRNA 网络中提取预后 lncRNA 和有用的生物信息非常困难。
基于 CRC 中的风险评分构建一个预后相关的 ceRNA 调控网络和 lncRNA 相关特征。
从癌症基因组图谱数据库中下载了 506 名 CRC 患者的 RNA 转录组谱和临床信息。使用 R 包和 Perl 程序进行数据处理。Cox 回归分析用于构建预后模型。使用实时定量聚合酶链反应检测 lncRNA 的表达。
构建了一个预后相关的 ceRNA 网络,包括 9 个 lncRNA、44 个 mRNAs 和 30 个 miRNAs。此外,使用多元 Cox 回归分析构建了一个四-lncRNA 模型,该模型可以作为 CRC 的独立预后模型。计算每个患者的风险评分,并根据中位数风险评分将 506 名患者分为高风险和低风险组(每组 253 名)。生存分析结果表明,高风险评分患者的生存率较差。此外,在 GSE38832 中评估了四-lncRNA 模型的预测价值。当结合风险评分和临床特征时,患者的生存概率可以得到更好的预测。基因集富集分析结果验证了在 CRC 中高风险评分富集了许多癌症相关的信号通路。最后,我们使用实时定量聚合酶链反应在 22 对 CRC 患者肿瘤组织与相邻非肿瘤组织比较中验证了一个新的 lncRNA()。
四-lncRNA 模型可为 CRC 患者提供更好的预测价值。我们对 lncRNA 相关 ceRNA 调控机制的理解可为 CRC 患者提供潜在的诊断指标。